companies making glp-1 drugs 2.0: Where the Next Wave of Value Will Be Created companies that make glp-1 drugs

Further research is needed to understand the link between Mounjaro and Dry Eye Syndrome, and it may be related to Mounjaros role in managing blood sugar levels in patients with type 2 diabetes

The next GLP-1 indicated for type 2 diabetes to lose exclusivity is Trulicity (dulaglutide) in 2027

Mozaffarian, A

Participants will need to meet whatever other requirements CMS puts in place, such as participating in lifestyle modifications

Microdosing seems like a middle ground between being on a full dose and going off the med cold turkey

And history has shown that the most effective medical interventions, such as bariatric surgery currently the gold standard for treating obesity often go unused in favor of dieting and exercise, which for many dont work